Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364-367

de Carvalho Luiz Sergio F.; Campos Alessandra M.; Sposito Andrei C.

首页> 外文期刊>Diabetes care >Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364-367

【24h】

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364-367

机译：Proprotein转化酶枯草杆菌蛋白酶/ kexin型9（PCSK9）抑制剂和入射2型糖尿病：系统评价和荟萃分析超过96,000例患者年。糖尿病护理2018; 41：364-367

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Diabetes care》 |2018年第4期|共2页
作者
de Carvalho Luiz Sergio F.; Campos Alessandra M.; Sposito Andrei C.;
展开▼
作者单位

Univ Estadual Campinas Dept Cardiol Campinas SP Brazil;

Univ Estadual Campinas Dept Cardiol Campinas SP Brazil;

Univ Estadual Campinas Dept Cardiol Campinas SP Brazil;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364-367 [J] . Cao Ye-Xuan, Li Jian-Jun Diabetes care . 2018,第4期

机译：Proprotein转化酶枯草杆菌蛋白酶/ kexin型9（PCSK9）抑制剂和入射2型糖尿病：系统评价和荟萃分析超过96,000例患者年。糖尿病护理2018; 41：364-367
2. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364-367 [J] . de Carvalho Luiz Sergio F., Campos Alessandra M., Sposito Andrei C. Diabetes care . 2018,第4期

机译：Proprotein转化酶枯草杆菌蛋白酶/ kexin型9（PCSK9）抑制剂和入射2型糖尿病：系统评价和荟萃分析超过96,000例患者年。糖尿病护理2018; 41：364-367
3. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364-367 [J] . de Carvalho Luiz Sergio F., Campos Alessandra M., Sposito Andrei C. Diabetes care . 2018,第4期

机译：Proprotein转化酶枯草杆菌蛋白酶/ kexin型9（PCSK9）抑制剂和入射2型糖尿病：系统评价和荟萃分析超过96,000例患者年。糖尿病护理2018; 41：364-367
4. Impact of Information Technology-Based Interventions for Type 2 Diabetes Mellitus on Glycaemic Control: a Systematic Review and Meta-Analysis [C] . NOUF ALHARBI, NAD A ALSUBKI, SIMON DE LUSIGNAN Medical Informatics in Europe Conference. . 2015

机译：基于信息技术的干预措施对血糖控制2型糖尿病的影响：系统审查和荟萃分析
5. Evaluation of the Interaction Between Proprotein Convertase Subtilisin/Kexin Type 9 and Sterol Carrier Protein-2 [D] . Ahranjani, Reza. 2017

机译：评价前蛋白转化酶枯草杆菌蛋白酶/ Kexin 9型与甾醇载体蛋白2的相互作用。
6. Association of circulating proprotein convertase subtilisin/kexin type 9 levels and the risk of incident type 2 diabetes in subjects with prediabetes: a population-based cohort study [O] . Jie Shi, Weiwei Zhang, Yixin Niu, 2020

机译：循环先驱转化酶枯草杆菌素/ kexin型9型水平及其在预先受试者中的事件2糖尿病的风险：基于人群的队列研究
7. Comment on de Carvalho et al. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364–367 [O] . Ye-Xuan Cao, Jian-Jun Li 2018

机译：评论de carvalho等。 Proprotein转化酶枯草杆菌蛋白酶/ kexin型9（PCSK9）抑制剂和入射2型糖尿病：系统评价和荟萃分析超过96,000例患者年。糖尿病护理2018; 41：364-367

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364-367

著录项

相似文献

相关主题

期刊订阅